carteolol


Also found in: Wikipedia.

carteolol

 [kahr´te-ah-lol]
a beta-adrenergic blocking agent with intrinsic sympathetic activity, administered orally as an antihypertensive and applied topically to the conjunctiva in the treatment of glaucoma and ocular hypertension.

carteolol

/car·te·o·lol/ (kahr´te-ah-lol) a beta-adrenergic blocking agent used as the hydrochloride salt in the treatment of hypertension and of glaucoma and ocular hypertension.

carteolol

[kär′te·älol]
a beta-adrenergic blocking agent with intrinsic sympathetic activity, administered orally as an antihypertensive and applied topically to the conjunctiva in the treatment of glaucoma and ocular hypertension.

carteolol

A β-blocker used to treat HTN. See Beta-blocker.

carteolol

A BETA-BLOCKER drug used as eyedrops in the treatment of GLAUCOMA. A brand name is Teoptic.

carteolol (kär´tēəlol),

n brand name: Cartrol;
drug class: nonselective β-adrenergic blocker;
action: competitively blocks stimulation of β-adrenergic receptors within vascular smooth muscle, decreases rate of sinoatrial (SA) node discharge, increases SA node recovery time;
use: mild to moderate hypertension.
carteolol HCl,
n brand name: Ocupress;
drug class: β-adrenergic blocker;
action: nonselective β-adrenergic blocking agent, reduces production of aqueous humor by unknown mechanisms;
uses: chronic open-angle glaucoma, ocular hypertension.
References in periodicals archive ?
Beta Blockers acebutolol, alprenolol, atenolol, betaxolol, bisoprolol, bunolol, carteolol, carvedilol, celiprolol, esmolol, labetalol, levobunolol, metipranolol, metoprolol, nadolol, oxprenolol, pindolol, propranolol, sotalol, timolol
The antiglaucoma beta blockers include betaxolol (Betoptic), carteolol (Ocupress), levobetaxolol (Betaxon), levobunolol (Betagan), metipranolol (Optipranolol) and timolol (Betimol, Timoptic, Istalol).
Severe breathing difficulties, including death from bronchial tube spasms, have been reported with carteolol, levobunolol, metipranolol and timolol.
Diabetes Antihypertensive Agent Hyperlipidemia mellitus (partial list) Diuretics: Hydrochlorothiazide High High (Hydrodiuril), Loop diuretic doses UF doses UF such as Furosemide Beta blocker with intrinsic F UF sympathomimetic activity: pindolol (Visken); carteolol HCL (Cartrol); acebutolol (Sectral); combined alpha/beta blocker: carvedilol (Coreg) Beta blocker without ISA: propranolol (Inderal); UF UF atenolol (Tenormin) [Alpha.
Timolol II-68 Levobunolol II-68 Carteolol II-68 Metipranolol II-69 Betaxolol II-69 Carbonic Anhydrase Inhibitors II-69 Prostaglandins II-69 Miotics II-69 Other Treatments II-69 Age-Related Macular Degeneration (AMD) II-70 Benign Prostatic Hyperplasia II-70 Dementia II-70 Alzheimer disease II-70 Menopause II-70 Age-Related Cardiovascular Diseases II-71 Sexual Dysfunction/Impotence II-71 Supplements for Age-Related Health Conditions II-71 Nutraceuticals II-72 Amino Acids II-72 Bay II-74
15 Percentage of patients who receive carteolol for the treatment of Hypertension
Since then, other topical beta-blockers, such as Betaxolol, Levohunolol, Carteolol and Meti-pranol have also become available.
Table 7: Global Osteoporosis Drug Market (2006): Breakdown of Value Sales of Leading Drug Brands - Fosamax, Evista, Boniva, Forteo, Actonel and Miacalcin (In US$ Million) (includes corresponding Graph/Chart) II-51 Osteoporosis Therapeutics: A Peek into the Major Brands II-52 Arthritis II-52 Cataract II-53 Glaucoma II-53 Anti- Glaucoma Ophthalmic Drugs II-53 Beta-Adrenergic Blockers or "Beta Blockers" II-54 Timolol II-54 Levobunolol II-54 Carteolol II-54 Metipranolol II-55 Betaxolol II-55 Carbonic Anhydrase Inhibitors II-55 Prostaglandins II-55 Miotics II-55 Other Treatments II-55
Revenues in the Americas region also benefited from higher sales of over-the-counter products due to a more severe allergy season, and European revenues benefited from higher sales of prescription pharmaceuticals, including a long-lasting version of carteolol introduced earlier in the year.
Ophthalmic sales in the 1999 period reflect the introduction of carteolol, the generic version of CIBA's Ocupress.
In anticipation of this event, Ciba Vision has given the marketing rights of the generic, Carteolol, to Akorn prior to 2000.
This arrangement will allow Ciba Vision to focus their efforts on their branded businesses while Akorn looks after the generic opportunities for Carteolol," said Dan Myers, President of Ciba Vision North American Ophthalmics.